CNS prophylaxis in aggressive lymphomas: for whom and how

被引：1
作者：
Benevolo, Giulia [1 ]
Chiappella, Annalisa [1 ]
Vitolo, Umberto [1 ]
机构：
[1] Citta Salute & Sci Hosp, Turin, Italy
来源：
HEMATOLOGICAL ONCOLOGY | 2013年 / 31卷
关键词：
Central nervous system; aggressive lymphoma; intrathecal chemotherapy; risk factors; rituximab; B-CELL LYMPHOMA; ELDERLY-PATIENTS; RISK-FACTORS; RITUXIMAB; RELAPSE; TESTIS; TRIAL;
D O I：
10.1002/hon.2074
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：89 / 91
页数：3
相关论文
共 15 条
  • [1] Double-hit B-cell lymphomas
    Aukema, Sietse M.
    Siebert, Reiner
    Schuuring, Ed
    van Imhoff, Gustaaf W.
    Kluin-Nelemans, Hanneke C.
    Boerma, Evert-Jan
    Kluin, Philip M.
    [J]. BLOOD, 2011, 117 (08) : 2319 - 2331
  • [2] Barosi G, 2006, HAEMATOLOGICA, V91, P96
  • [3] Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination
    Benevolo, Giulia
    Stacchini, Alessandra
    Spina, Michele
    Ferreri, Andres J. M.
    Arras, Marcella
    Bellio, Laura
    Botto, Barbara
    Bulian, Pietro
    Cantonetti, Maria
    Depaoli, Lorella
    Di Renzo, Nicola
    Di Rocco, Alice
    Evangelista, Andrea
    Franceschetti, Silvia
    Godio, Laura
    Mannelli, Francesco
    Pavone, Vincenzo
    Pioltelli, Pietro
    Vitolo, Umberto
    Pogliani, Enrico M.
    [J]. BLOOD, 2012, 120 (16) : 3222 - 3228
  • [4] Diagnosis and treatment of central nervous system involvement in non-Hodgkin's Lymphoma
    Bierman, P
    Giglio, P
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2005, 19 (04) : 597 - +
  • [5] CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
    Boehme, Volkmar
    Schmitz, Norbert
    Zeynalova, Samira
    Loeffler, Markus
    Pfreundschuh, Michael
    [J]. BLOOD, 2009, 113 (17) : 3896 - 3902
  • [6] Conconi A, 2013, LEUKEMIA LYMPHOMA, P1
  • [7] Dreyling M, 2012, LEUKEMIA LYMPHOMA, P1
  • [8] Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab
    Feugier, P
    Virion, JM
    Tilly, H
    Haioun, C
    Marit, G
    Macro, M
    Bordessoule, D
    Recher, C
    Blanc, M
    Molina, T
    Lederlin, P
    Coiffier, B
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (01) : 129 - 133
  • [9] How I treat mantle cell lymphoma
    Ghielmini, Michele
    Zucca, Emanuele
    [J]. BLOOD, 2009, 114 (08) : 1469 - 1476
  • [10] Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature
    Guirguis, Hany R.
    Cheung, Matthew C.
    Mahrous, Mervat
    Piliotis, Eugenia
    Berinstein, Neil
    Imrie, Kevin R.
    Zhang, Liying
    Buckstein, Rena
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (01) : 39 - 49
12